Injectable Reproductive Hormone Market Size, Share & Industry Analysis, By Type (Estrogen, Progesterone, Testosterone, Combination Products), By Applications (Infertility Treatment, Contraception, Menstruation Disorders, Sexual Dysfunction, Others), By End users (Hospitals, Specialty clinics, Others) Pfizer, Xianju Pharma, American Regent, Zydus Cadila, Actiza Pharmaceutical, Empower Pharmacy,Others and Regional Forecast, 2024-2032

Reproductive Hormone refers to a hormone that is involved in fertility and sexuality. These reproductive hormones are usually made in the testes and ovaries in male and female reproductive system respectively. Wherein, female reproductive hormones consist of progesterone and estrogen and male reproductive hormone include testosterone which in developing and maintaining sex characteristics of both female and male. They play major role in female characteristics such as fertility, pregnancy, and menstrual cycle. Where as in male they help in formation of sperms in the testes. These reproductive hormones can be formed in laboratory and used to for the treatment of various medical conditions. Furthermore, they are also used for the treatment, prevention, improvement of disease, symptoms, and conditions which include vasomotor symptoms associated with menopause, vaginal and vulvar atrophy associated with hypoestrogenism, hypogonadism, ovarian failure, and others is also triggering the growth of the market.

Rise in adoption of injectable hormones for normal reproductive functioning, rise in innovative products for reproductive injectable, growing awareness related to sexual health and reproductive, treatment of prostate cancer, are the major factors driving growth of the market during forecast period. According to World Cancer report, cancer cases will be increasing by 50% to 15 million new cases by 2020 which is also anticipated to positively influence the market growth. Furthermore, use of estrogen to treat symptoms of menopause which include vaginal dryness, hot flashes, burning, irritation, and others is also influencing the growth of the market in near future. It is also used in treatment of lack of estrogen that occurs due to ovarian failure called as hypogonadism which is boosting the growth of the market. Additionally, these injectable hormones also help in birth controlling by progestin and an estrogen combination of these invectives helps in preventing pregnancy. For instance, the injections by name Cyclofem and Mesigyna consists of synthetic forms of the estrogen and progestin hormones formed by the body which destroy pituitary gland and stops ovaries from liberating eggs leading to prevention of pregnancies. These injections can also change the uterus lining and mucus in your cervix which makes difficult for sperms to reach eggs. Thus Estrogen and progestin hormonal injections are highly effective in prevention of pregnancy which is significantly influencing the growth of the market.

However, lack of skilled professionals, lack of technology penetration, stringent regulations, side effects due to these injectable are hampering the growth of market during the forecast period. For instance, Estrogen rises the risk that leads to occurrence of endometrial cancer, omitting, weight gain or loss, dizziness, nervousness, depression, irritability, and others. These hormones also effect eating habits such as Progesterone increases the food intake, Testosterone also Stimulates food intake, and others.

Market Segmentation:

Globally, the injectable reproductive hormone market is segmented on bases of product type, estrogen, progesterone, and testosterone. Based on the applications, the market is segmented into infertility treatment, contraception’s, menstruation disorders, sexual dysfunction, and others. Based on the end users, the market is classified into hospitals, specialty clinics, and others.

Geographically, the global Injectable Reproductive Hormone market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

Key Players Covered:

The major companies in the global injectable reproductive hormone market include  Pfizer, Xianju Pharma, American Regent, Zydus Cadila, Actiza Pharmaceutical, Empower Pharmacy, ABBVIE, Bayer, Endo Pharmaceuticals, Mayne Pharma, Allergan and others.

Key Insights:

• Pipeline Analysis, Key Players


• New Product Launches


• Key Industry Developments


• Pricing Analysis

Regional Analysis:

Geographically, the global injectable reproductive hormone market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the market owing technological advancements, huge investment in the healthcare industry, and the quick adoption of technology. Europe is the second-largest contributor to the market owing to an increase in health care awareness, increased capita income expenditure, increased healthcare infrastructure. Asia Pacific is anticipated to experience vast growth in the market owing to rise in geriatric population, an increase in healthcare awareness, and an increase in government initiatives towards the healthcare sector, and an increase in the number of research activities, and others. Latin America and Middle East are also anticipated to experience lucrative growth in the market.

Segmentation

Injectable Reproductive Hormone Industry Developments

• In October 2018, FDA approved testosterone self-injection for hypogonadism in men with primary hypogonadism or hypogonadotropic hypogonadism.